The endoplasmic reticulum is traditionally perceived as the key compartment for regulating intracellular cholesterol metabolism. Increasing evidence suggests that the endocytic pathway provides an additional regulatory level governing intracellular cholesterol trafficking and homoeostasis. Sterols can enter, and apparently also exit, endosomal compartments via both vesicular and non-vesicular mechanisms. A number of studies have focused on endosomal sterol removal as its defects lead to cholesterol storage diseases. So far, the bulk of evidence on endosomal sterol egress describes the involvement of membrane trafficking machineries. Interestingly, two late endosomal sterol-binding proteins were recently shown to regulate the movement of late endosomes along cytoskeletal tracks. These studies provide the first indications of how non-vesicular and vesicular mechanisms may co-operate in endosomal sterol trafficking.
Introduction
Endosomes receive cholesterol from two major sources: the endocytic pathway is the entry point of lipoproteinderived cholesterol into the cell, but even in the absence of lipoproteins, membrane cholesterol is continuously recycled between the plasma membrane and endosomes. Furthermore, endosomes contain cholesterol in variable amounts: recycling endosomes and the internal membranes of multivesicular bodies are cholesterol-enriched, whereas lysosomes are normally cholesterol poor [1, 2] . The maintenance of differential cholesterol content between endosome populations as well as within endosomal domains requires efficient systems for cholesterol sorting and recycling from different stations. The mechanisms by which this is achieved are beginning to emerge.
Endocytic trafficking of cholesterol by membrane transport
The LDL (low-density lipoprotein) particles are delivered into cells via receptor-mediated endocytosis and transported to the terminal hydrolytic compartments [3] . In LDL, most of the cholesterol is present as fatty acyl esters, which become hydrolysed by acid lipase. Apparently, cholesteryl ester hydrolysis is initiated before the particle delivery to lysosomes [4] . The LDL receptor returns to the cell surface via recycling endosomes, but the precise trafficking itineraries of LDL-derived cholesterol remain elusive. The freed cholesterol is transported to the plasma membrane and the ER (endoplasmic reticulum), eventually resulting in an increase in Key words: cholesterol, endosomal sterol-binding protein, lysosomal storage disease, Rab protein, sterol transport. Abbreviations used: ABCA1, ATP-binding cassette A1; ER, endoplasmic reticulum; GDI, GDP dissociation inhibitor; LDL, low-density lipoprotein; MLN64, metastatic lymph node 64; NPC, Niemann-Pick type C; OSBP, oxysterol-binding protein; ORP, OSBP-related protein; StAR, steroidogenic acute regulatory protein; START, StAR-related lipid transfer. 1 To whom correspondence should be addressed (email elina.ikonen@helsinki.fi).
cholesterol esterification and down-regulation of cholesterol biosynthesis. Dissection of the precise transport steps has, however, been problematic, owing to methodological constraints. Microscopic approaches for the visualization of cholesterol have limitations [5] , and biochemical analyses require equilibration time-scales that preclude detailed analysis of intermediate transport steps.
Several lysosomal storage disorders as well as administration of certain amphiphilic compounds lead to cholesterol accumulation in late endocytic compartments. In these systems, it has been possible to address the effects of cholesterol accumulation on endocytic membrane transport and vice versa. For instance, mutations in NPC1 (Niemann-Pick type C 1) or NPC2 genes lead to a condition where cholesterol and other lipids accumulate in late endocytic organelles. This phenotype is accompanied by perturbations in the dynamic properties of the storage organelles, such as motility and tubulation [6, 7] . However, at present, it is not clear what the primary defect is. One possibility is that NPC protein(s) are directly involved in the regulation of vesicular trafficking, as has been suggested for NPC1 [7] . Alternatively, impaired organelle dynamics could be a secondary phenomenon resulting from the cholesterol accumulation [6] .
More direct evidence for the involvement of vesicular transport in cholesterol trafficking comes from studies where vesicular transport machineries have been manipulated. Rab GTPases are among the key regulators of vesicular trafficking, and perturbation of their function with Rab-GDI (GDP dissociation inhibitor) was shown to impair cholesterol removal from late endocytic organelles [8] . Also, overexpression of Rab7 or Rab9 has been reported to reduce cholesterol accumulation in late endosomes/lysosomes [9, 10] . In addition to late endosomes, endosomal recycling routes participate in sterol transport. While the recycling endosomes may acquire cholesterol by non-vesicular mechanisms [1] , the recycling of sterols to the cell surface appears to be regulated by the same molecules that mediate the vesicular trafficking of other recycling cargo, such as Rab11 [11] and Rme-1 [1] . Excess cholesterol has been shown to perturb the extractability of Rab7 and Rab4 proteins by GDI, thus interfering with their functional cycle [6, 12] . Interestingly, in the same studies, Rab5 and Rab11 proteins were found to be insensitive to the membrane cholesterol content. If some Rab proteins are more 'tolerant' of high cholesterol and retain their activity irrespective of membrane cholesterol level, it could have significance in directing cholesterol flow to certain pathways at the expense of others.
Non-vesicular mechanisms of cholesterol transport
Owing to its hydrophobicity, cholesterol desorbs slowly from membranes [13] . To occur with physiologically relevant kinetics, non-vesicular sterol transport would require that the donor and acceptor membranes be brought very close to one another and/or that the process be assisted by sterol-binding proteins. A non-vesicular process has been shown to mediate sterol delivery to recycling endosomes. The fluorescent sterol, dehydroergosterol, can be rapidly internalized from the plasma membrane and become transported to recycling endosomes or lipid droplets [1, 14] . In accordance with a nonvesicular mechanism, this transport was shown to be fast and not to require metabolic energy. The delivery to recycling endosomes takes place in fixed cells, too [1] . This suggests that the process depends on biophysical properties of the acceptor membrane, providing high affinity for cholesterol, rather than protein carriers.
Electron microscopy reveals that heterologous membranes frequently form zones of close apposition, termed membrane contact sites [15] . Such sites have been visualized for instance between the ER and other organelles, and they have been suggested to function in intracellular trafficking of small molecules. For cholesterol and other lipids, the ER could work as a dispatcher between different organelles via membrane contact sites, analogous to Ca 2+ transport [16] . These contact sites have also been shown to harbour lipid transfer proteins, which could greatly facilitate the movement of lipids between adjacent membranes [16] .
Endosomal sterol-binding proteins
A lipid-binding domain may, but does not necessarily, imply that the protein functions as a lipid transporter. Alternatively, lipid binding may have a regulatory function or it could facilitate membrane or protein interaction. For instance, both the NPC proteins have been shown to interact with cholesterol, NPC1 via its sterol-sensing domain [17] and NPC2 through a novel hydrophobic ligand-binding domain reminiscent of the Ig-fold [18] . The significance of the interaction of the NPC1 sterol-sensing domain with cholesterol remains to be elucidated. Sterol-sensing domains in other proteins have been associated with regulatory rather than direct transport functions [19] . For NPC2, a direct cholesterol transporter function, possibly in the intraendosomal/lysosomal milieu, has been suggested [20] .
Yet another type of a cholesterol-binding domain is shared by proteins containing START [StAR (steroidogenic acute regulatory protein)-related lipid transfer] domain [21] . Three of the START family members have been shown to bind cholesterol, namely StAR, MLN64 (metastatic lymph node 64) and STARD5 (StAR-domain-containing protein 5) [22] [23] [24] . Of these, MLN64 is anchored to the late endosomal membrane, and is suggested to participate in late endosomal cholesterol export [21, 23] . The family of ORPs [OSBP (oxysterol-binding protein)-related proteins] encode a lipidbinding barrel reminiscent of that of START-domain proteins [25] . OSBP, the founding member of this family, binds cholesterol [26] . Interestingly, ORP1 has been found to localize to late endosomes [27] and also to bind sterols [27a] . Moreover, ORP1 has been shown to enhance the transactivation potential of liver X receptors, and is suggested to participate in sterol metabolism [27] .
In addition, recent data indicate that the ABCA1 (ATPbinding cassette A1)-mediated cholesterol efflux to apolipoprotein AI may take place in endosomes [28, 29] . ABCA1 itself recycles between the plasma membrane and late endosomes [28] . A plasma-membrane trapped form of ABCA1 is unable to promote cholesterol efflux from late endosomes, whereas the wild-type protein is [29] . Thus lipid transfer proteins may require vesicular transport for proper function. This is also true for NPC2 that is strictly dependent on mannose-6-phosphate receptors for correct delivery to lysosomes [30] .
Non-vesicular and vesicular mechanisms meet in the endocytic pathway
While sterol-binding proteins may participate in non-vesicular sterol transport, two recent studies showed unexpectedly that the modulation of endosomal sterol-binding proteins primarily affected membrane trafficking. Knockdown of MLN64 had no obvious effect on cellular sterol homoeostasis [31, 32] but instead impaired the association of late endosomes with actin, leading to organelle scattering and inhibition of endo/lysosomal degradation [32] . In this scenario, MLN64-mediated sterol binding and transport would have local effects on the endosome membrane, thereby regulating actin association. On the other hand, ORP1 was shown to interact with Rab7, stabilizing its membrane association [33] . The potential significance of ORP1 sterol binding in this process is not known. However, considering that cholesterol modulates the membrane association of Rab7 [6] , a local sterol sensing/transfer function in the endosome membrane seems possible. These observations leave open the option that endosomal sterol-binding proteins may function in inter-organellar sterol transfer, such as the formation of membrane contact sites. For instance, the effects of MLN64 and ORP1 on endosome motility and positioning could be important for regulating the tethering of endosomes to other subcellular membranes to facilitate sterol transfer.
Another interesting interface between non-vesicular and vesicular sterol transport arises from the organization of the endosomes themselves. In late endosomes, the internal membranes differ from the limiting membrane in both lipid and protein composition. According to the current understanding, cholesterol located in the internal membranes of endosomes needs to be shuttled to the limiting membrane in order to be transported further [34] . Such sterol shuttle functions have been proposed for instance for NPC2 [20] and MLN64 [21] as well as lysobisphosphatidic acid, a late endosomal lipid that induces membrane curvature of the internal membranes [35] . These non-vesicular mechanisms within an endosome could have significant effects on sterol homoeostasis. For example, it has been shown that if endosome membranes are not cleared of accumulating cholesterol, the hydrolysis of lipoprotein-derived cholesteryl esters stalls [36] .
The emerging interplay between vesicular and non-vesicular cholesterol transport processes at the endosome level is intriguing. It seems likely that several systems operate in parallel, providing flexibility and redundancy. One could envision that non-vesicular mechanisms, especially those operating on the basis of biophysical forces, could facilitate transportation of large amounts of sterol very rapidly. This type of transport may take place for instance in situations when cholesterol is flooding some compartment, e.g. endosomes or plasma membrane, and rapid ER translocation for sterol esterification becomes necessary. On the other hand, mechanisms of membrane transport could assist in the precise regulation required in the maintenance of cholesterol gradients between different compartments or membrane domains. Failures in these mechanisms have serious consequences, leading to a diversity of pathologies [37] . A more thorough understanding of the basic mechanisms of endosomal cholesterol traffic will undoubtedly pay off as better measures evolve to prevent or eliminate abnormal sterol deposition.
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